OGI (Organigram Global) NonCurrent Deferred Revenue: $0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OGI Organigram Global Inc OGI
66 GF Score
Price $1.20
GF Value $1.86
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Organigram Global NonCurrent Deferred Revenue?

Organigram Global OGI +1.27% 66 NonCurrent Deferred Revenue is $0.0 Mil as of Jun. 2026. GuruFocus rates OGI with a GF Score™ of 66/100 and a GF Value™ of $1.86 (Possible Value Trap). The stock has 4 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

Organigram Global's non-current deferred revenue for the quarter that ended in Jun. 2026 was $0.0 Mil.

Organigram Global NonCurrent Deferred Revenue Related Terms

Organigram Global NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Organigram Global's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organigram Global NonCurrent Deferred Revenue Chart

Organigram Global Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24 Sep25
NonCurrent Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Organigram Global Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OGI
66GF Score
Organigram Global Inc OGI
NonCurrent Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Revenue of $0.0 Mil mean?
Organigram Global (OGI) has a NonCurrent Deferred Revenue of $0.0 Mil as of Jun. 2026. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Organigram Global and its competitors.
Is Organigram Global's NonCurrent Deferred Revenue too high?
Organigram Global's current NonCurrent Deferred Revenue is $0.0 Mil. Overall, Organigram Global has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organigram Global's NonCurrent Deferred Revenue compare to ZTS?
Organigram Global's NonCurrent Deferred Revenue of $0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Drug Manufacturers company?
A good NonCurrent Deferred Revenue depends on the Drug Manufacturers industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Organigram Global and its competitors. Organigram Global's current NonCurrent Deferred Revenue is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organigram Global stock overvalued right now?
Based on GuruFocus' analysis, Organigram Global (OGI) is currently considered Possible Value Trap. The stock's GF Value™ is $1.86, compared to a current price of $1.20 — trading 35.8% below its estimated fair value. The current NonCurrent Deferred Revenue is $0.0 Mil. Organigram Global's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For Organigram Global (OGI), the current NonCurrent Deferred Revenue is $0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organigram Global (OGI) Overvalued in 2026?

Based on GuruFocus' analysis, Organigram Global stock appears to be undervalued. The current stock price of $1.20 is trading 35.8% below its estimated GF Value™ of $1.86. GuruFocus considers Organigram Global to be Possible Value Trap.

Key valuation signals for OGI:

  • NonCurrent Deferred Revenue: $0.0 Mil
  • GF Value™: $1.86 vs. price of $1.20 (35.8% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the OGI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Organigram Global Business Description

Other Exchanges 0OG:GermanyOGI:Canada
Address 145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
66GF Score

Get the complete analysis for OGI

NonCurrent Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.20
Price
$1.86
GF Value